WebUsing this framework examples of potential interventions to improve the prevention, recognition and response to harms due to high risk medicines have been developed based on feedback from key stakeholders and networks (updated May 2024 - clozapine and lithium added). Webto ensure the Trust is compliant with the NPSA 2009/PSA005 “Safer Lithium Therapy” alert. 1.2 This version supersedes any previous versions of this document. 2. Purpose of this Policy/Procedure To provide clear actions that need to be taken by medical, nursing and pharmacy staff when a patient taking lithium is admitted to RCHT.

Guidelines on the Safe use of Lithium in Adults version 1 2 - HPFT

Web1730.pdf Version 2.0 (updated to reflect Patient Safety Alert, April 2024 – Sodium valproate). Developed by Pharmacy & Medicines Optimisation Team, Herts Valleys CCG. WebThe increase in lithium levels varies from 25–400% Loop diuretics also cause lithium retention but are less likely to result in lithium toxicity. Nonsteroidal anti-inflammatory … chip phase 5

Safe prescribing of high-risk drugs NICE

Web1. Has the patient had all baseline tests completed as per lithium PGN & shared care guideline? Y/N (If N, please describe follow up plans) 2. Has the patient been on a stable lithium dose for at least 4 weeks? Y/N (If N, please describe follow up monitoring plans) 3. Has the patient been provided with (or already have) a Lithium NPSA (purple) WebIn the five years to December 2009, the National Patient Safety Agency recorded 560 patient safety incidents relating to the use of lithium. One of the key themes the NPSA … WebPPT-PGN-19 – Safer Lithium Therapy – V03 – Issue 2 –RepairLink-Sec11-Pg9 – Apr 16 Part of NTW(C)38 – Pharmacological Therapy Policy 2 1.8 In December 2009 the National Patient Safety Agency (NPSA) issued a Patient Safety Alert on safer lithium therapy: NPSA Patient Safety Alert – Safer lithium therapy (NPSA 2009/PSA005). chip phelps